Skip to main content
RESTART LIFE SCIENCES logo

RESTART LIFE SCIENCES — Investor Relations & Filings

Ticker · HEAL CSE Manufacturing
Open in API
Filings indexed 204 across all filing types
Latest filing 2025-04-08 Regulatory Filings
Country CA Canada
Listing CSE HEAL

About RESTART LIFE SCIENCES

https://restartlife.co/

Restart Life Sciences Corp. is a life sciences company focused on the research, development, and delivery of innovative wellness solutions designed to address contemporary health and lifestyle challenges. The company utilizes science and technology to advance well-being, with a strategic emphasis on nutritional health and natural remedies. Its portfolio includes brands such as BrainBalls and BrainQ. Furthermore, the company is expanding its focus on gut health and better-for-you food products through the acquisition of the Holy Crap Foods portfolio of brands, integrating advanced food technology into its core business activities.

Recent filings

Filing Released Lang Actions
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Form 13-502F1 submission to the Ontario Securities Commission under OSC Rule 13-502 Fees. It details quarterly market values, fee calculations, and management certification for payment of participation fees. This is a regulatory compliance filing, not an earnings report, proxy statement, or presentation. It best fits the general “Regulatory Filings” category (RNS).
2025-04-08 English
Audited annual financial statements – English.pdf
Regulatory Filings
2025-04-08 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is clearly a press/news release announcing a strategic trademark licensing agreement and contains forward‐looking statements. It is not an earnings release, capital raise, merger, share transaction, or formal financial report (annual, interim, or ESG). It is essentially a regulatory press announcement of a business update, which falls under the general Regulatory Filings category.
2025-03-17 English
Material change report - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a Canadian NI 51-102F3 Material Change Report disclosing the closing of a debt settlement transaction and the issuance of common share units, warrants, stock options, and RSUs. These are financing activities and capital structure changes rather than an AGM presentation, earnings release, or other category. Therefore it best fits the Capital/Financing Update category.
2025-02-19 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a corporate press release announcing the securing of a production partnership and details of a debt settlement transaction (issuance of units with warrants) plus granting of stock options and RSUs. These items relate to capital structure and financing activities (share issuance, debt settlement). This aligns with the Capital/Financing Update (CAP) category.
2025-02-19 English
Report of exempt distribution (45-106F1) (amended).pdf
Regulatory Filings Classification · 1% confidence The document is a Canadian securities regulatory form (Form 45-106F1 Report of Exempt Distribution) detailing the exempt distribution of securities, including purchaser schedules, distribution details, and compensation disclosures. It is not an annual or interim financial report, earnings release, management presentation, or other specific US-style filing. It is a mandatory regulatory submission under NI 45-106 and does not fit any of the narrow categories except the general fallback for miscellaneous regulatory filings. Therefore, it should be classified as Regulatory Filings (RNS).
2025-02-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.